Ascendis Pharma A/S vs Weibo Corp — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Weibo Corp trades at $7.77 (market cap $1.93B). The key difference: Ascendis Pharma A/S is far larger — about 8.6× Weibo Corp's market cap, and Weibo Corp pays a 7.75% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | WB | |
|---|---|---|
Market Cap | $16.67B | $1.93B |
Sector | Health | Media |
52-Week High | $277.18 | $12.83 |
52-Week Low | $189.74 | $7.20 |
Enterprise Value | $17.04B | $1.20B |
Dividend Yield | — | 7.75% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →